Sana Biotechnology, Inc. is working on a gene therapy to cure Type 1 diabetes. Click here to find out why SANA stock is a ...

Many pet insurance companies cover select alternative treatments, while others may cover them through add-ons.

Syndax received expanded FDA approval for Revuforj, tripling its addressable AML patient population despite a boxed safety ...

Genenta intends to use the net proceeds from the offering for working capital and general corporate purposes. The offering is expected to close on or about October 28, 2025, subject to the ...

BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ: BRTX), a clinical stage company focused on stem cell-based therapies, today announced it has entered into definitive ...

The challenge with curing the Human Immunodeficiency Virus (HIV) is that it tends to hide dormant in cells, evading the ...

Although teplizumab doesn’t work for everyone and how much it delays progression varies, it has inspired new directions in ...

Novo Nordisk licensed a clinical-stage MASP-3 inhibitor from Omeros. Omeros is eligible to receive $340 million upfront, ...

The new luxury for the ultra-high-net-worth individual is not a product but time, driving a trillion-dollar global wellness ...

Keep reading if you'd like a glimpse into 10 of the fabulous ways the rich spend their money, at least according to ChatGPT.

Ingestible electronics. Microneedle patches. A capsule that could replace insulin shots. In Giovanni Traverso’s lab, the ...

On one wall of endocrinologist Kevan Herold’s office hangs artwork by a girl who joined one of his type 1 diabetes trials when she was 11 years old. The girl was diagnosed with stage 2 of the disease, ...